Artera

artera.ai

Artera is a leading precision medicine company developing AI tests to personalize cancer therapy. The company offers AI-enabled predictive and prognostic cancer tests, including the first of its kind for patients with localized prostate cancer: the Artera AI Prostate Test. This multimodal artificial intelligence (MMAI) test analyzes digital pathology images and clinical data to predict therapy benefits and long-term outcomes, enabling personalized treatment decisions. Artera's innovative approach is supported by robust clinical data and has been recognized in the NCCN Clinical Practice Guidelines for Prostate Cancer, positioning it as a key player in the oncology market.